209 related articles for article (PubMed ID: 30090001)
1. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
Daskalakis K; Tsolakis AV
World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001
[TBL] [Abstract][Full Text] [Related]
2. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
3. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
4. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
5. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
6. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
Gangi A; Anaya DA
Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
[TBL] [Abstract][Full Text] [Related]
7. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
9. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
[TBL] [Abstract][Full Text] [Related]
10. Indication for liver transplantation in young patients with small intestinal NETs is rare?
Norlén O; Daskalakis K; Öberg K; Åkerström G; Stålberg P; Hellman P
World J Surg; 2014 Mar; 38(3):742-7. PubMed ID: 24233660
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors.
Eriksson J; Garmo H; Hellman P; Ihre-Lundgren C
Ann Surg Oncol; 2017 May; 24(5):1214-1220. PubMed ID: 27904972
[TBL] [Abstract][Full Text] [Related]
12. Value of ileus-prophylactic surgery for metastatic neuroendocrine midgut tumours.
Weber F; Dralle H
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101342. PubMed ID: 31628078
[TBL] [Abstract][Full Text] [Related]
13. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
14. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of neuroendocrine tumors.
Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of cytoreductive operations for peritoneal carcinomatosis with or without liver cytoreduction in patients with small bowel neuroendocrine tumors.
Wonn SM; Limbach KE; Pommier SJ; Ratzlaff AN; Leon EJ; McCully BH; Pommier RF
Surgery; 2021 Jan; 169(1):168-174. PubMed ID: 32473829
[TBL] [Abstract][Full Text] [Related]
17. [Indications and operative procedures for neuroendocrine liver metastases].
Musholt TJ; Lang H
Chirurg; 2009 Feb; 80(2):113-21. PubMed ID: 19212693
[TBL] [Abstract][Full Text] [Related]
18. Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question.
Dijke K; Kuhlmann KFD; Levy S; Tesselaar MET
Curr Oncol Rep; 2023 Jun; 25(6):679-688. PubMed ID: 37004701
[TBL] [Abstract][Full Text] [Related]
19. Role of Primary Tumor Resection for Metastatic Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):213-218. PubMed ID: 32797281
[TBL] [Abstract][Full Text] [Related]
20. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
